Academic literature on the topic 'Antitrypanosomal agents'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antitrypanosomal agents.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antitrypanosomal agents"

1

Steverding, Dietmar, and Kevin M. Tyler. "Novel antitrypanosomal agents." Expert Opinion on Investigational Drugs 14, no. 8 (July 29, 2005): 939–55. http://dx.doi.org/10.1517/13543784.14.8.939.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Issa, Victor Sarli, and Edimar Alcides Bocchi. "Antitrypanosomal agents: treatment or threat?" Lancet 376, no. 9743 (September 2010): 768. http://dx.doi.org/10.1016/s0140-6736(10)61372-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Schmidt, Ines, Sarah Göllner, Antje Fuß, August Stich, Anna Kucharski, Tanja Schirmeister, Elena Katzowitsch, et al. "Bistacrines as potential antitrypanosomal agents." Bioorganic & Medicinal Chemistry 25, no. 16 (August 2017): 4526–31. http://dx.doi.org/10.1016/j.bmc.2017.06.051.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ryczak, Jasmin, Ma'ayan Papini, Annette Lader, Abedelmajeed Nasereddin, Dmitry Kopelyanskiy, Lutz Preu, Charles L. Jaffe, and Conrad Kunick. "2-Arylpaullones are selective antitrypanosomal agents." European Journal of Medicinal Chemistry 64 (June 2013): 396–400. http://dx.doi.org/10.1016/j.ejmech.2013.03.065.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rassi, Anis, Anis Rassi, and José Antonio Marin-Neto. "Antitrypanosomal agents: treatment or threat? – Authors' reply." Lancet 376, no. 9743 (September 2010): 768–69. http://dx.doi.org/10.1016/s0140-6736(10)61373-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Silva, Daniel G., J. Robert Gillespie, Ranae M. Ranade, Zackary M. Herbst, Uyen T. T. Nguyen, Frederick S. Buckner, Carlos A. Montanari, and Michael H. Gelb. "New Class of Antitrypanosomal Agents Based on Imidazopyridines." ACS Medicinal Chemistry Letters 8, no. 7 (June 29, 2017): 766–70. http://dx.doi.org/10.1021/acsmedchemlett.7b00202.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ding, Dazhong, Yaxue Zhao, Qingqing Meng, Dongsheng Xie, Bakela Nare, Daitao Chen, Cyrus J. Bacchi, et al. "Discovery of Novel Benzoxaborole-Based Potent Antitrypanosomal Agents." ACS Medicinal Chemistry Letters 1, no. 4 (April 6, 2010): 165–69. http://dx.doi.org/10.1021/ml100013s.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rodríguez Arce, Esteban, Eugenia Putzu, Michel Lapier, Juan Diego Maya, Claudio Olea Azar, Gustavo A. Echeverría, Oscar E. Piro, et al. "New heterobimetallic ferrocenyl derivatives are promising antitrypanosomal agents." Dalton Transactions 48, no. 22 (2019): 7644–58. http://dx.doi.org/10.1039/c9dt01317b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Qiao, Zhitao, Qi Wang, Fenglong Zhang, Zhongli Wang, Tana Bowling, Bakela Nare, Robert T. Jacobs, et al. "Chalcone–Benzoxaborole Hybrid Molecules as Potent Antitrypanosomal Agents." Journal of Medicinal Chemistry 55, no. 7 (March 14, 2012): 3553–57. http://dx.doi.org/10.1021/jm2012408.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Papadopoulou, Maria V., William D. Bloomer, Howard S. Rosenzweig, Ivan P. O'Shea, Shane R. Wilkinson, and Marcel Kaiser. "3-Nitrotriazole-based piperazides as potent antitrypanosomal agents." European Journal of Medicinal Chemistry 103 (October 2015): 325–34. http://dx.doi.org/10.1016/j.ejmech.2015.08.042.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Antitrypanosomal agents"

1

Clark, Rachel L. "The development of new broad spectrum antitrypanosomal agents." Thesis, University of Strathclyde, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.415310.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zulu, Ayanda Ignatia. "Synthesis and evaluation of arylpyrrole-chalcone hybrids as antiplasmodial and antitrypanosomal agents." Thesis, Rhodes University, 2017. http://hdl.handle.net/10962/65268.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sola, I., A. Artigas, M. C. Taylor, F. J. Perez-Areales, E. Viayna, M. V. Clos, B. Perez, Colin W. Wright, J. M. Kelly, and D. Muñoz-Torrero. "Synthesis and biological evaluation of N-cyanoalkyl-, Naminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents." 2016. http://hdl.handle.net/10454/8940.

Full text
Abstract:
Yes
Current drugs against human African trypanosomiasis (HAT) suffer from several serious drawbacks. The search for novel, effective, brain permeable, safe, and inexpensive antitrypanosomal compounds is therefore an urgent need. We have recently reported that the 4-aminoquinoline derivative huprine Y, developed in our group as an anticholinesterasic agent, exhibits a submicromolar potency against Trypanosoma brucei and that its homo- and hetero-dimerization can result in to up to three-fold increased potency and selectivity. As an alternative strategy towards more potent smaller molecule anti-HAT agents, we have explored the introduction of ω-cyanoalkyl, ω-aminoalkyl, or ω-guanidinoalkyl chains at the primary amino group of huprine or the simplified 4-aminoquinoline analogue tacrine. Here, we describe the evaluation of a small in-house library and a second generation of newly synthesized derivatives, which has led to the identification of 13 side chain modified 4-aminoquinoline derivatives with submicromolar potencies against T. brucei. Among these compounds, the guanidinononyltacrine analogue 15e exhibits a 5-fold increased antitrypanosomal potency, 10-fold increased selectivity, and 100-fold decreased anticholinesterasic activity relative to the parent huprine Y. Its biological profile, lower molecular weight relative to dimeric compounds, reduced lipophilicity, and ease of synthesis, make it an interesting anti-HAT lead, amenable to further optimization to eliminate its remaining anticholinesterasic activity.
Wellcome Trust
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Antitrypanosomal agents"

1

Kryshchyshyn, Anna, Danylo Kaminskyy, Philippe Grellier, and Roman Lesyk. "Thiazolidinone-Related Heterocyclic Compounds as Potential Antitrypanosomal Agents." In Azoles - Synthesis, Properties, Applications and Perspectives [Working Title]. IntechOpen, 2020. http://dx.doi.org/10.5772/intechopen.91861.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Antitrypanosomal agents"

1

Suckling, Colin J., Fraser Scott, Abedawn Khalaf, Kirsten Gillingwater, Liam Morrison, Harry de Koning, Michael Barrett, and Federica Giordani. "Minor Groove Binders for DNA as Antitrypanosomal Agents: the Veterinary Context." In 3rd International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2017. http://dx.doi.org/10.3390/ecmc-3-04647.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography